Drug Discovery & Development Products & Reviews

From laboratory to pilot scale, YMC offers reliable, high quality glass columns for all kind of application areas.

YMC PilotPLUS columns are completely biocompatible and characterised by safe and easy handling.

Does your application require customised pilot columns? With YMC Pilot columns, customised versions can be constructed to address your needs. Of course standard dimensions are available, too!

Chaotrope-induced protein precipitation & proteome profiling (CHIPP™) is a readily scalable, label-free assay for the study of drug: target interactions.

wavePREP is an efficient, rapid, and safe tool for the post-processing step in the oligos production. Its process combines cleavage and deprotection into a single step, ensuring both a superior workflow and product yields by removing the evaporation phase.

The Milestone synthWAVE is designed for safe, reliable and reproducible scale-up of microwave enhanced chemical reactions. The synthWAVE is capable of higher temperature and pressure than any other microwave reactors. Milestone synthWAVE features the unmatched Single Reaction Chamber (SRC) patented technology that ensures scale, reaction screening, highest temperature and pressure. It is able to handle single or multiple react…

The new Milestone flexiWAVE overcomes the limitation of conventional microwave synthesis reactors, as it consists of a single microwave platform that, in combination with specific accessories, allows the chemists to perform classic glassware and high pressure synthesis, as well as solid-phase reactions.

Cloud-based software solution for bioprocess monitoring and analysis

Lynx Certified Disposable Tips are manufactured in GMP clean-room conditions, with gamma irradiation and in-line visual QA inspection, ensuring sterility and reliability. Packaged in ANSI-standard tip boxes, they integrate seamlessly across Lynx decks—making tip handling safe, flexible, and maintenance-free.

On the Fly, Swappable, Multipurpose Tools! The Multi-Core Pipetting Arm (MCPA), Lynx offers seamless core swapping, increased throughput, and ultimate flexibility — empowering labs to do more, faster.

Elephas Live™ Platform: Ex vivo cytokine profiling enables precision medicine

Plasmax™ is a physiologically relevant cell culture medium which closely mimics the nutritional & metabolic profile of human plasma, containing over 80 optimised components.

Syngeneic urothelial carcinoma model for bladder cancer research and immunotherapy development

KCGS is a comprehensive collection of 295 highly selective kinase inhibitors targeting 262 human kinases

Syngeneic pancreatic ductal adenocarcinoma (PDA) cell line from the KPC mouse model for immune-competent studies in drug discovery, biomarker development, genetic research, and metastasis

Our Metabolite Identification service for peptides utilizes HRMS to characterize peptide metabolism (e.g., hydrolysis, oxidation, glucuronidation). The assay identifies and semi-quantifies metabolites in plasma/tissues, enabling ADME profiling (clearance, bioavailability), toxicity screening (reactive metabolites) and peptide optimization (PK/PD enhancement). Integrated with preclinical data, it supports metabolically stable p…

Our Comprehensive In Vitro Proarrhythmia Assay (CiPA) service assesses proarrhythmic potential of compounds beyond hERG inhibition, integrating effects on multiple cardiac ion channels and human iPSC-derived cardiomyocytes via patch clamp and multi-well MEA platforms. Aligned with FDA's CiPA initiative and ICH E14/S7B guidelines, it predicts QT prolongation and TdP risks for enhanced specificity in early drug safety evaluation…

Our Protein Binding Platform assesses drug-protein interactions using equilibrium dialysis and ultracentrifugation methods to determine unbound fractions and distribution in biological samples including plasma, blood, tissues, and cells. This essential ADME service evaluates reversible drug transfer between compartments, providing insights into pharmacokinetics, bioavailability, and potential interactions.

Our hERG Safety Screening service employs the Synchropatch-384 automated patch clamp system to assess compound effects on the hERG potassium channel. This high-throughput assay detects inhibitors that may prolong QT intervals and cause arrhythmias, aiding early drug safety evaluation. With precise data under physiological conditions, it supports regulatory compliance to advance safer therapeutics.